Table 1

Patient characteristics

ADL, activities of daily living; H&Y, Hoehn and Yahr; MI, motor impairment; S&E, Schwab and England.
Number of patients85
Mean (SD) age (y)65.4 (10.4)
Number (%) males52 (61.2)
Mean (SD) disease duration (y)10.5 (5.8)
H&Y stage
    10
    225
    342
    418
    50
Mean (SD) SPES/SCOPA-MI13.8 (5.1)
Mean (SD) SPES/SCOPA-ADL8.5 (3.2)
Mean (SD) UPDRS-motor evaluation32.6 (10.9)
Mean (SD) UPDRS-ADL15.9 (6.0)
Mean (SD) S&E75.7 (12.4)
Number assessed while “on”/“off”/missing78/5/2
Number (%) on levodopa72 (84.7)
Mean (SD) levodopa dose (mg) in users535 (407)
Number (%) on dopamine agonists63 (74.1)